U.S. Markets close in 4 mins.

Lupin Limited (LUPIN.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,140.20-88.30 (-7.19%)
At close: 3:30PM IST
Interactive chart
Previous Close1,228.50
Bid0.00 x
Ask0.00 x
Day's Range1,107.00 - 1,180.00
52 Week Range1,107.00 - 1,750.00
Avg. Volume937,544
Market Cap514.34B
PE Ratio (TTM)17.61
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reutersyesterday

    Indian drugmaker Lupin warns of more pricing pressure as Q4 profit halves

    Indian drugmaker Lupin Ltd expects to launch over 30 products in the United States this year, but warned revenue growth would remain muted due to growing pricing pressure and competition in the world's largest healthcare market. "We've talked about medium single digits of price erosion in the past and I think we are now (seeing) high single digits," Managing Director Nilesh Gupta told Reuters after Lupin reported a quarterly profit that halved from a year earlier. The country's third-largest drugmaker has been working on building a pipeline of high-value complex generic drugs in the United States to offset growing competition in plain generics.

  • Reuters7 days ago

    India's drug pricing regulator clamps down on drug cocktails

    India's drug pricing regulator has demanded explanations from 65 domestic and global drugmakers for selling new forms of essential diabetes and antibiotic drugs without its approval. The move could bring penalties for the drugmakers, among them Abbott Laboratories, Sanofi, Novartis and Indian firms such as Sun Pharmaceutical Industries and Lupin, the National Pharmaceutical Pricing Authority (NPPA) said on its website.

  • Bloomberg3 months ago

    Lupin CFO Says $1 Billion M&A War Chest May Be Just The Start

    Lupin Ltd.’s point man for mergers and acquisitions figures he has about $1 billion to work with as he hunts for targets to hasten the Indian firm’s move from simple generic drugs to more profitable products. ...